Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias

Nikolay V. Dokholyan; Richard C. Mohs; Randall J. Bateman

doi:10.1002/trc2.12330

Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias

Nikolay V. Dokholyan, Richard C. Mohs, Randall J. Bateman

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

The health, well-being, and financial security of Americans are greatly impacted by Alzheimer's disease. The forecast paints an upward trajectory with the number of Americans suffering from Alzheimer's disease and related dementia. To discuss the Alzheimer's crisis, The Senate Committee on Finance, Subcommittee on Health Care, held a hearing titled, “The Alzheimer's Crisis: Examining, Testing, and Treatment Pipelines and Fiscal Implications,” on December 16, 2020. Here, we summarize and expand on the discussion of the panel and its review of recent progress, ongoing challenges associated with Alzheimer's disease, and potential initiatives that promise to speed progress in developing treatments and improving care.

Original language	English
Article number	e12330
Journal	Alzheimer's and Dementia: Translational Research and Clinical Interventions
Volume	8
Issue number	1
DOIs	https://doi.org/10.1002/trc2.12330
State	Published - 2022
Externally published	Yes

Keywords

ADRD
Alzheimer's disease
dementia
healthcare policy

Access to Document

10.1002/trc2.12330

Cite this

@article{1a6d07137ed346eca8455c49b2b0dd2f,

title = "Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias",

abstract = "The health, well-being, and financial security of Americans are greatly impacted by Alzheimer's disease. The forecast paints an upward trajectory with the number of Americans suffering from Alzheimer's disease and related dementia. To discuss the Alzheimer's crisis, The Senate Committee on Finance, Subcommittee on Health Care, held a hearing titled, “The Alzheimer's Crisis: Examining, Testing, and Treatment Pipelines and Fiscal Implications,” on December 16, 2020. Here, we summarize and expand on the discussion of the panel and its review of recent progress, ongoing challenges associated with Alzheimer's disease, and potential initiatives that promise to speed progress in developing treatments and improving care.",

keywords = "ADRD, Alzheimer's disease, dementia, healthcare policy",

author = "Dokholyan, {Nikolay V.} and Mohs, {Richard C.} and Bateman, {Randall J.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.",

year = "2022",

doi = "10.1002/trc2.12330",

language = "English",

volume = "8",

journal = "Alzheimer's and Dementia: Translational Research and Clinical Interventions",

issn = "2352-8737",

publisher = "John Wiley & Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias

AU - Dokholyan, Nikolay V.

AU - Mohs, Richard C.

AU - Bateman, Randall J.

PY - 2022

Y1 - 2022

N2 - The health, well-being, and financial security of Americans are greatly impacted by Alzheimer's disease. The forecast paints an upward trajectory with the number of Americans suffering from Alzheimer's disease and related dementia. To discuss the Alzheimer's crisis, The Senate Committee on Finance, Subcommittee on Health Care, held a hearing titled, “The Alzheimer's Crisis: Examining, Testing, and Treatment Pipelines and Fiscal Implications,” on December 16, 2020. Here, we summarize and expand on the discussion of the panel and its review of recent progress, ongoing challenges associated with Alzheimer's disease, and potential initiatives that promise to speed progress in developing treatments and improving care.

AB - The health, well-being, and financial security of Americans are greatly impacted by Alzheimer's disease. The forecast paints an upward trajectory with the number of Americans suffering from Alzheimer's disease and related dementia. To discuss the Alzheimer's crisis, The Senate Committee on Finance, Subcommittee on Health Care, held a hearing titled, “The Alzheimer's Crisis: Examining, Testing, and Treatment Pipelines and Fiscal Implications,” on December 16, 2020. Here, we summarize and expand on the discussion of the panel and its review of recent progress, ongoing challenges associated with Alzheimer's disease, and potential initiatives that promise to speed progress in developing treatments and improving care.

KW - ADRD

KW - Alzheimer's disease

KW - dementia

KW - healthcare policy

UR - http://www.scopus.com/inward/record.url?scp=85145084148&partnerID=8YFLogxK

U2 - 10.1002/trc2.12330

DO - 10.1002/trc2.12330

M3 - Article

AN - SCOPUS:85145084148

SN - 2352-8737

VL - 8

JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions

JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions

IS - 1

M1 - e12330

ER -

Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias

Abstract

Keywords

Access to Document

Fingerprint

Cite this